Skip to main content
Log in

Effective microorganism substance (EM-S) reduces development and aggravation of atopic dermatitis-like skin lesions in NC/Nga mice

  • Bioactive Meterials
  • Article
  • Published:
Journal of the Korean Society for Applied Biological Chemistry Submit manuscript

Abstract

In a previous study, our group showed that the effective microorganism substance (EM-S) produced by fermentation of medicinal plants with effective microorganisms has an antiinflammatory effect on atopic dermatitis-like lesions in NC/Nga mice. However, the possible antiinflammatory effect and skin barrier function of EM-S for inflammatory cell infiltration, Interleukin-4 (IL-4) production, C-C chemokine receptor 10 (CCR10), and filaggrin (FLG) expression were not reported. Therefore, effects of EM-S on the development of atopic dermatitislike skin lesions in NC/Nga mice were evaluated. Efficacy of EM-S was judged by measurement of scratching behavior, T-cell subset infiltration, cytokine production, and FLG expression. Topical application of EM-S significantly reduced scratching behavior in NC/Nga mice caused by house dust mite antigen (Dermatophagoides farinse extract, DfE) sensitization. IL-4 production and CD4+ and CD45+ cell infiltrations were significantly reduced by EM-S. CCR10 expression was also significantly inhibited by EM-S. EM-S treatment also increased the level of FLG reduced by DfE sensitization. These results demonstrate EM-S, when applied topically, may be an effective substance for management of atopic dermatitis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aruoma OI, Deiana M, Rosa A, Casu V, Piga R, Assunta Dessì M, Ke B, Liang YF, and Higa T (2002) Assessment of the ability of the antioxidant cocktail-derived from fermentation of plants with effective microorganisms (EM-X) to modulate oxidative damage in the kidney and liver of rats in vivo: studies upon the profile of poly- and monounsaturated fatty acids. Toxicol Lett 135, 209–217.

    Article  CAS  Google Scholar 

  • Boguniewicz M (2004) Update on atopic dermatitis: insights into pathogenesis and new treatment paradigms. Allergy Asthma Proc 25, 279–282.

    Google Scholar 

  • Chui CH, Hau DK, Lau FY, Cheng GY, Wong RS, Gambari R, Kok SH, Lai KB, Teo IT, Leung TW, Higa T, Ke B, Tang JC, Fong DW, and Chan AS (2006) Apoptotic potential of the concentrated effective microorganism fermentation extract on human cancer cells. Int J Mol Med 17, 279–284.

    Google Scholar 

  • Datla KP, Bennett RD, Zbarsky V, Ke B, Liang YF, Higa T, Bahorun T, Aruoma OI, and Dexter DT (2004) The antioxidant drink effective microorganism-X (EM-X) pretreatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson’s disease. J Pharm Pharmacol 56, 649–654.

    Article  CAS  Google Scholar 

  • Deiana M, Dessi MA, Ke B, Liang YF, Higa T, Gilmour PS, Jen LS, Rahman I, and Aruoma OI (2002) The antioxidant cocktail effective microorganism X (EM-X) inhibits oxidant-induced interleukin-8 release and the peroxidation of phospholipids in vitro. Biochem Biophys Res Commun 296, 1148–1151.

    Article  CAS  Google Scholar 

  • Do JS, Seo HJ, Hwang JK, Kim JH, and Nam SY (2007) Effective microorganism fermentation extract (EM-X) attenuates airway hyperreactivity and inflammation through selective inhibition of the TH2 response independently of antioxidant activity. Int J Mol Med 20, 631–635.

    CAS  Google Scholar 

  • Dubrac S, Schmuth M, and Ebner S (2010) Atopic dermatitis: the role of Langerhans cells in disease pathogenesis. Immunol Cell Biol 88, 400–409.

    Article  Google Scholar 

  • Fallon PG, Sasaki T, Sandilands A, Campbell LE, Saunders SP, Mangan NE, Callanan JJ, Kawasaki H, Shiohama A, Kubo A, Sundberg JP, Presland RB, Fleckman P, Shimizu N, Kudoh J, Irvine AD, Amagai M, and McLean WH (2009) A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 41, 602–608.

    Article  CAS  Google Scholar 

  • Homey B, Alenius H, Müller A, Soto H, Bowman EP, Yuan W, McEvoy L, Lauerma AI, Assmann T, Bünemann E, Lehto M, Wolff H, Yen D, Marxhausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, and Zlotnik A (2002) CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8, 157–165.

    Article  CAS  Google Scholar 

  • Homey B, Steinhoff M, Ruzicka T, and Leung DY (2006) Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118, 178–189.

    Article  CAS  Google Scholar 

  • Homey B, Wang W, Soto H, Buchanan ME, Wiesenborn A, Catron D, Müller A, McClanahan TK, Dieu-Nosjean MC, Orozco R, Ruzicka T, Lehmann P, Oldham E, and Zlotnik A (2000) Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 164, 3465–3470.

    CAS  Google Scholar 

  • Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, Schneider L, Beck LA, Barnes KC, and Leung DY (2007) Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 120, 150–155.

    Article  CAS  Google Scholar 

  • Kang JS, Lee K, Han SB, Ahn JM, Lee H, Han MH, Yoon YD, Yoon WK, Park SK, and Kim HM (2006) Induction of atopic eczema/dermatitis syndrome-like skin lesions by repeated topical application of a crude extract of Dermatophagoides pteronyssinus in NC/Nga mice. Int Immunopharmacol 6, 1616–1622.

    Article  CAS  Google Scholar 

  • Ke B, Xu Z, Ling Y, Qiu W, Xu Y, Higa T, and Aruoma OI (2009) Modulation of experimental osteoporosis in rats by the antioxidant beverage effective microorganism-X (EMX). Biomed Pharmacother 63, 114–119.

    Article  CAS  Google Scholar 

  • Kurahashi R, Hatano Y, and Katagiri K (2008) IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo. J Invest Dermatol 128, 1329–1331.

    Article  CAS  Google Scholar 

  • Leung DY (2009) Our evolving understanding of the functional role of filaggrin in atopic dermatitis. J Allergy Clin Immunol 124, 494–495.

    Article  CAS  Google Scholar 

  • Marenholz I, Nickel R, Rüschendorf F, Schulz F, Esparza-Gordillo J, Kerscher T, Grüber C, Lau S, Worm M, Keil T, Kurek M, Zaluga E, Wahn U, and Lee YA (2006) Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 118, 866–871.

    Article  CAS  Google Scholar 

  • Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, and Ra C (1997) Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9, 461–466.

    Article  CAS  Google Scholar 

  • Mihara K, Kuratani K, Matsui T, Nakamura M, and Yokota K (2004) Vital role of the itch-scratch response in development of spontaneous dermatitis in NC/Nga mice. Br J Dermatol 151, 335–345.

    Article  CAS  Google Scholar 

  • Mok JY, Jeong SI, Cho JK, Choi JW, Nam SY, Chang WG, Moon BE, Park KH, and Jang SI (2010) Anti-inflammatory effects of effective microorganism fermentation substance on atopic dermatitis-like NC/Nga mouse model. Korean J Orien Physiol Phathol 24, 258–265.

    Google Scholar 

  • Morales J, Homey B, Vicari AP, Hudak S, Oldham E, Hedrick J, Orozco R, Copeland NG, Jenkins NA, McEvoy LM, and Zlotnik A (1999) CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 96, 14470–14475.

    Article  CAS  Google Scholar 

  • Nakazato J, Kishida M, Kuroiwa R, Fujiwara J, Shimoda M, and Shinomiya N (2008) Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatr Allergy Immunol 19, 605–613.

    Google Scholar 

  • Noh SU, Cho EA, Kim HO, and Park YM (2008) Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC/Nga mice by suppressing macrophage migration inhibitory factor. Int Immunopharmacol 8, 1172–1182.

    Article  CAS  Google Scholar 

  • Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, and Leung DY (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171, 3262–3269.

    CAS  Google Scholar 

  • Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O’Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, and McLean WH (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38, 441–446.

    Article  CAS  Google Scholar 

  • Simpson EL (2010) Atopic dermatitis: a review of topical treatment options. Curr Med Res Opin 26, 633–640.

    Article  CAS  Google Scholar 

  • Soler D, Humphreys TL, Spinola SM, and Campbell JJ (2003) CCR4 versus CCR10 in human cutaneous Th lymphocyte trafficking. Blood 101, 1677–1682.dt]Article

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to and Seon Il Jang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, KH., Jeong, SI., Mok, J.Y. et al. Effective microorganism substance (EM-S) reduces development and aggravation of atopic dermatitis-like skin lesions in NC/Nga mice. J. Korean Soc. Appl. Biol. Chem. 54, 211–220 (2011). https://doi.org/10.3839/jksabc.2011.035

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.3839/jksabc.2011.035

Key words

Navigation